<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Peter Attia</title>
	<atom:link href="https://peterattiamd.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://peterattiamd.com/</link>
	<description></description>
	<lastBuildDate>Mon, 08 Jun 2026 03:46:26 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://peterattiamd.com/wp-content/uploads/2023/04/cropped-apple-icon-32x32.png</url>
	<title>Peter Attia</title>
	<link>https://peterattiamd.com/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>#395 &#8211; Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer&#8217;s disease risk, and the effects of lipid-lowering therapies on brain health &#124; Tom Dayspring, M.D.</title>
		<link>https://peterattiamd.com/tomdayspring8/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 08 Jun 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[Cardiovascular Disease]]></category>
		<category><![CDATA[Cognitive Health & Neurodegenerative Disease]]></category>
		<category><![CDATA[Guest Episodes]]></category>
		<category><![CDATA[Longevity]]></category>
		<category><![CDATA[Medications]]></category>
		<category><![CDATA[Medications & supplements]]></category>
		<category><![CDATA[Preventing Chronic Disease]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[Atherosclerosis]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[brain health]]></category>
		<category><![CDATA[cholesterol]]></category>
		<category><![CDATA[dementia]]></category>
		<category><![CDATA[Diseases - Alzheimer's disease]]></category>
		<category><![CDATA[Diseases - dementia]]></category>
		<category><![CDATA[Drugs - CETPi - anacetrapib]]></category>
		<category><![CDATA[Drugs - CETPi - dalcetrapib]]></category>
		<category><![CDATA[Drugs - CETPi - evacetrapib]]></category>
		<category><![CDATA[Drugs - CETPi - obicetrapib]]></category>
		<category><![CDATA[Drugs - CETPi - torcetrapib]]></category>
		<category><![CDATA[Drugs - statins]]></category>
		<category><![CDATA[Drugs - statins - atorvastatin (Lipitor)]]></category>
		<category><![CDATA[Drugs - statins - hydrophilic statins]]></category>
		<category><![CDATA[Drugs - statins - lipophilic statins]]></category>
		<category><![CDATA[Drugs - statins - pravastatin (Pravachol)]]></category>
		<category><![CDATA[Drugs - statins - rosuvastatin (Crestor)]]></category>
		<category><![CDATA[Drugs - statins - simvastatin (Zocor)]]></category>
		<category><![CDATA[Fats - DHA]]></category>
		<category><![CDATA[Fats - EPA]]></category>
		<category><![CDATA[Fats - omega-3]]></category>
		<category><![CDATA[Fats - omega-6]]></category>
		<category><![CDATA[Genes - APOE4]]></category>
		<category><![CDATA[LDL]]></category>
		<category><![CDATA[lipoproteins]]></category>
		<category><![CDATA[Lipoproteins - apoB]]></category>
		<category><![CDATA[Lipoproteins - apoB-100]]></category>
		<category><![CDATA[Lipoproteins - apoB-48]]></category>
		<category><![CDATA[Lipoproteins - apoE]]></category>
		<category><![CDATA[Lipoproteins - CETP]]></category>
		<category><![CDATA[Lipoproteins - HDL]]></category>
		<category><![CDATA[Lipoproteins - HDL functionality]]></category>
		<category><![CDATA[Lipoproteins - HDL-C]]></category>
		<category><![CDATA[Lipoproteins - HDL-P]]></category>
		<category><![CDATA[Lipoproteins - LDL]]></category>
		<category><![CDATA[Lipoproteins - LDL-C]]></category>
		<category><![CDATA[Lipoproteins - LDL-P]]></category>
		<category><![CDATA[Lipoproteins - non-HDL-C]]></category>
		<category><![CDATA[Neurodegeneration]]></category>
		<category><![CDATA[Neurodegeneration - Alzheimer's disease]]></category>
		<category><![CDATA[Neurodegeneration - amyloid hypothesis]]></category>
		<category><![CDATA[Neurodegeneration - dementia]]></category>
		<category><![CDATA[Neurodegeneration - tau]]></category>
		<category><![CDATA[omega-3]]></category>
		<category><![CDATA[Supplements - fish oil]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=39103</guid>

					<description><![CDATA[<p>"Unfortunately, a prevalent belief out there in the real world is ‘I don't ever want to lower LDL cholesterol too much, because I'll deprive the brain and I'll injure the brain’ . . .and that is not true." —Tom Dayspring</p>
<p>The post <a href="https://peterattiamd.com/tomdayspring8/">#395 &#8211; Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer&#8217;s disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>The beginning of the end of atherosclerosis?</title>
		<link>https://peterattiamd.com/the-beginning-of-the-end-of-atherosclerosis/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 06 Jun 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All risks]]></category>
		<category><![CDATA[Cardiovascular Disease]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Cardiovascular Disease (CVD)]]></category>
		<category><![CDATA[Drugs - PCSK9i]]></category>
		<category><![CDATA[Lipoproteins - PCSK9]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=39073</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">An early trial for a gene therapy that targets PCSK9 and profoundly lowers lipids</span></p>
<p>The post <a href="https://peterattiamd.com/the-beginning-of-the-end-of-atherosclerosis/">The beginning of the end of atherosclerosis?</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>#394 ‒ Sleep pharmacology: the role of medications in healthy sleep, the promise of emerging therapies, and the evidence for common sleep supplements</title>
		<link>https://peterattiamd.com/sleeppharmacology/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 01 Jun 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[Medications & supplements]]></category>
		<category><![CDATA[Sleep]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[Drugs - Pregabalin (for sleep)]]></category>
		<category><![CDATA[Drugs - trazodone (for sleep)]]></category>
		<category><![CDATA[Sleep - blue light]]></category>
		<category><![CDATA[Sleep - insomnia]]></category>
		<category><![CDATA[Sleep - jet lag]]></category>
		<category><![CDATA[Sleep - sleeping pills]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38214</guid>

					<description><![CDATA[<p>“Different drugs vary in how quickly they work, how long they last, and which sleep problems they target. We need to match the medication's pharmacology to the patient's specific sleep challenges.” —Peter Attia</p>
<p>The post <a href="https://peterattiamd.com/sleeppharmacology/">#394 ‒ Sleep pharmacology: the role of medications in healthy sleep, the promise of emerging therapies, and the evidence for common sleep supplements</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Resistance training: lowering the barrier to entry</title>
		<link>https://peterattiamd.com/lowering-the-barrier-to-entry-for-resistance-training/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 30 May 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All exercise]]></category>
		<category><![CDATA[Exercise]]></category>
		<category><![CDATA[Strength & Muscle Mass]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Muscle - muscular strength]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38167</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">Optimized programs with heavy weights are the gold standard for trained athletes. How much do they matter when starting fresh?</span></p>
<p>The post <a href="https://peterattiamd.com/lowering-the-barrier-to-entry-for-resistance-training/">Resistance training: lowering the barrier to entry</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Growth hormone for musculoskeletal system repair</title>
		<link>https://peterattiamd.com/growth-hormone-for-musculoskeletal-system-repair/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Tue, 26 May 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All medications & supplements]]></category>
		<category><![CDATA[Medications]]></category>
		<category><![CDATA[Medications & supplements]]></category>
		<category><![CDATA[Premium Articles]]></category>
		<category><![CDATA[Hormones - growth hormone]]></category>
		<category><![CDATA[Hormones - IGF-1]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38157</guid>

					<description><![CDATA[<p>Despite the mechanism, growth hormone has not delivered on its promise for adult tissue repair</p>
<p>The post <a href="https://peterattiamd.com/growth-hormone-for-musculoskeletal-system-repair/">Growth hormone for musculoskeletal system repair</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>#393 ‒ AMA #85: A guide to medications and supplements: determining what to take, what to skip, and how to know if they’re working for you</title>
		<link>https://peterattiamd.com/ama85/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 25 May 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[All medications & supplements]]></category>
		<category><![CDATA[Ask Me Anything (AMA)]]></category>
		<category><![CDATA[Hormone replacement therapy]]></category>
		<category><![CDATA[Medications]]></category>
		<category><![CDATA[Medications & supplements]]></category>
		<category><![CDATA[Supplements]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[ascvd]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer - breast cancer]]></category>
		<category><![CDATA[Cardiovascular Disease (CVD)]]></category>
		<category><![CDATA[Diseases - Heart Disease]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Drugs - generic drugs]]></category>
		<category><![CDATA[Drugs - GLP-1]]></category>
		<category><![CDATA[Drugs - rapalogs]]></category>
		<category><![CDATA[Drugs - rapamycin]]></category>
		<category><![CDATA[Electrolytes]]></category>
		<category><![CDATA[Fats - DHA]]></category>
		<category><![CDATA[Fats - EPA]]></category>
		<category><![CDATA[Fiber]]></category>
		<category><![CDATA[medications]]></category>
		<category><![CDATA[Metabolism - NAD]]></category>
		<category><![CDATA[Metabolism - NAD+/NADH]]></category>
		<category><![CDATA[Metabolism - NADH]]></category>
		<category><![CDATA[Nutrition - Fiber]]></category>
		<category><![CDATA[Nutritional biochemistry - protein]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[Rapamycin]]></category>
		<category><![CDATA[Studies - absolute risk]]></category>
		<category><![CDATA[Studies - relative risk]]></category>
		<category><![CDATA[Supplements - ashwagandha]]></category>
		<category><![CDATA[Supplements - creatine]]></category>
		<category><![CDATA[Supplements - fish oil]]></category>
		<category><![CDATA[Supplements - magnesium]]></category>
		<category><![CDATA[Supplements - magnesium L-threonate]]></category>
		<category><![CDATA[Supplements - nicotinamide mononucleotide (NMN)]]></category>
		<category><![CDATA[Supplements - nicotinamide riboside (NR)]]></category>
		<category><![CDATA[Supplements - vitamin D]]></category>
		<category><![CDATA[Supplements - whey protein]]></category>
		<category><![CDATA[Treatments - NAD precursors]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38187</guid>

					<description><![CDATA[<p>“Poor problem definition almost guarantees some sort of false positive.” —Peter Attia</p>
<p>The post <a href="https://peterattiamd.com/ama85/">#393 ‒ AMA #85: A guide to medications and supplements: determining what to take, what to skip, and how to know if they’re working for you</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		<enclosure url="https://peterattiamd.com/mp-files/ama-85-full-audio.mp3/" length="0" type="audio/mpeg" />

			</item>
		<item>
		<title>What at-home HPV testing means for cervical cancer screening</title>
		<link>https://peterattiamd.com/cervical-cancer-screening/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 23 May 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All risks]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Viruses - HPV]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38102</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">Pap smears transformed cervical cancer prevention. Now, self-collected HPV testing may help more women stay up to date on screening.</span></p>
<p>The post <a href="https://peterattiamd.com/cervical-cancer-screening/">What at-home HPV testing means for cervical cancer screening</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>#392 &#8211; Genetic testing: when it&#8217;s valuable, how to choose the right test, and what to do with the results</title>
		<link>https://peterattiamd.com/genetictesting/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 18 May 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cardiovascular Disease]]></category>
		<category><![CDATA[Cholesterol]]></category>
		<category><![CDATA[Cognitive Health & Neurodegenerative Disease]]></category>
		<category><![CDATA[High Blood Pressure]]></category>
		<category><![CDATA[Hormones]]></category>
		<category><![CDATA[Insulin Resistance]]></category>
		<category><![CDATA[Metabolic health]]></category>
		<category><![CDATA[Other tactics, tools, & treatments]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[ascvd]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Cancer - breast cancer]]></category>
		<category><![CDATA[Cancer - cancer as a metabolic disease]]></category>
		<category><![CDATA[Cardiovascular Disease (CVD)]]></category>
		<category><![CDATA[dementia]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[Diabetes - prediabetes]]></category>
		<category><![CDATA[Diseases - Alzheimer's disease]]></category>
		<category><![CDATA[Diseases - dementia]]></category>
		<category><![CDATA[Diseases - diabetes]]></category>
		<category><![CDATA[Diseases - Heart Disease]]></category>
		<category><![CDATA[Diseases - type 1 diabetes]]></category>
		<category><![CDATA[Diseases - type 2 diabetes]]></category>
		<category><![CDATA[Enzymes - COMT]]></category>
		<category><![CDATA[gene editing]]></category>
		<category><![CDATA[Genes - APOE4]]></category>
		<category><![CDATA[Genes - BRAF]]></category>
		<category><![CDATA[Genes - DNA]]></category>
		<category><![CDATA[Genes - gene sequencing]]></category>
		<category><![CDATA[Genes - genetic testing]]></category>
		<category><![CDATA[Genes - genetics]]></category>
		<category><![CDATA[Genes - genome atlas project]]></category>
		<category><![CDATA[Genes - MTHFR]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[Genetics - SNPs]]></category>
		<category><![CDATA[heart]]></category>
		<category><![CDATA[Heart Disease]]></category>
		<category><![CDATA[metabolic health]]></category>
		<category><![CDATA[Neurodegeneration]]></category>
		<category><![CDATA[Neurodegeneration - Alzheimer's disease]]></category>
		<category><![CDATA[Neurodegeneration - dementia]]></category>
		<category><![CDATA[Syndromes - Lynch syndrome]]></category>
		<category><![CDATA[Syndromes - metabolic syndrome]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38142</guid>

					<description><![CDATA[<p>“Like every tool we have in medicine, [genetic testing] has real strengths and real limitations, and its value depends almost entirely on how thoughtfully it is used.” —Peter Attia</p>
<p>The post <a href="https://peterattiamd.com/genetictesting/">#392 &#8211; Genetic testing: when it&#8217;s valuable, how to choose the right test, and what to do with the results</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>A critical look at ultra-processed diets and male reproductive health</title>
		<link>https://peterattiamd.com/ultra-processed-diets-and-reproductive-health/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 16 May 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All nutrition]]></category>
		<category><![CDATA[All risks]]></category>
		<category><![CDATA[Nutrition]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Diets]]></category>
		<category><![CDATA[Reproductive health]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38100</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">What a controlled feeding study in young men can—and cannot—tell us about ultra-processed foods.</span></p>
<p>The post <a href="https://peterattiamd.com/ultra-processed-diets-and-reproductive-health/">A critical look at ultra-processed diets and male reproductive health</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>#391 ‒ Colorectal cancer screening: importance of early screening, colonoscopy as a screening and preventive tool, and how to build a personalized strategy</title>
		<link>https://peterattiamd.com/colorectalcancerscreening/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 11 May 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[Cancer - cancer screening]]></category>
		<category><![CDATA[Cancer - colon cancer]]></category>
		<category><![CDATA[Cancer - colonoscopy]]></category>
		<category><![CDATA[Diseases - inflammatory bowel disease (IBD)]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38089</guid>

					<description><![CDATA[<p>“Most cancers are something that happen to you, but colorectal cancer is one of the few that you can intercept before it even exists.” —Peter Attia</p>
<p>The post <a href="https://peterattiamd.com/colorectalcancerscreening/">#391 ‒ Colorectal cancer screening: importance of early screening, colonoscopy as a screening and preventive tool, and how to build a personalized strategy</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		<enclosure url="https://peterattiamd.com/mp-files/colorectal-cancer-screening-full-audio.mp3/" length="0" type="audio/mpeg" />

			</item>
		<item>
		<title>The dynamic physiology of the brain with menopause </title>
		<link>https://peterattiamd.com/menopause-and-brain-function/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 09 May 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All risks]]></category>
		<category><![CDATA[Hormones]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Menopause]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38075</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">Menopause is often framed as a reproductive milestone. Brain imaging data suggest it may also be a neurological one.</span></p>
<p>The post <a href="https://peterattiamd.com/menopause-and-brain-function/">The dynamic physiology of the brain with menopause </a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>#390 ‒ AMA #84: Family health history, preventing heart disease, metabolic health, strength training efficiency, dementia risk reduction, NAD supplements, and hydration</title>
		<link>https://peterattiamd.com/ama84/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 04 May 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[All longevity]]></category>
		<category><![CDATA[Ask Me Anything (AMA)]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cardiovascular Disease]]></category>
		<category><![CDATA[Cognitive Health & Neurodegenerative Disease]]></category>
		<category><![CDATA[Exercise]]></category>
		<category><![CDATA[Longevity]]></category>
		<category><![CDATA[Medications & supplements]]></category>
		<category><![CDATA[Metabolic health]]></category>
		<category><![CDATA[Other tactics, tools, & treatments]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Strength & Muscle Mass]]></category>
		<category><![CDATA[Supplements]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[ascvd]]></category>
		<category><![CDATA[Cancer - cancer screening]]></category>
		<category><![CDATA[Cardiovascular Disease (CVD)]]></category>
		<category><![CDATA[Conditions - metabolic dysfunction]]></category>
		<category><![CDATA[Dehydration]]></category>
		<category><![CDATA[dementia]]></category>
		<category><![CDATA[Diseases - Alzheimer's disease]]></category>
		<category><![CDATA[Diseases - dementia]]></category>
		<category><![CDATA[Diseases - Heart Disease]]></category>
		<category><![CDATA[Diseases - metabolic disease]]></category>
		<category><![CDATA[Drugs - Alzheimer's disease drugs]]></category>
		<category><![CDATA[Exercise - resistance exercise]]></category>
		<category><![CDATA[Exercise - resistance training]]></category>
		<category><![CDATA[Heart Disease]]></category>
		<category><![CDATA[Hydration]]></category>
		<category><![CDATA[metabolic health]]></category>
		<category><![CDATA[Metabolism - NAD]]></category>
		<category><![CDATA[Metabolism - NAD+/NADH]]></category>
		<category><![CDATA[Metabolism - NADH]]></category>
		<category><![CDATA[Muscle - muscular strength]]></category>
		<category><![CDATA[Neurodegeneration]]></category>
		<category><![CDATA[Neurodegeneration - Alzheimer's disease]]></category>
		<category><![CDATA[Neurodegeneration - dementia]]></category>
		<category><![CDATA[Screening - family history]]></category>
		<category><![CDATA[Supplements - nicotinamide mononucleotide (NMN)]]></category>
		<category><![CDATA[Supplements - nicotinamide riboside]]></category>
		<category><![CDATA[Supplements - nicotinamide riboside (NR)]]></category>
		<category><![CDATA[Syndromes - metabolic syndrome]]></category>
		<category><![CDATA[Treatments - NAD precursors]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38040</guid>

					<description><![CDATA[<p>“There's a risk to doing anything, and then there's a risk to NOT doing something.” —Peter Attia</p>
<p>The post <a href="https://peterattiamd.com/ama84/">#390 ‒ AMA #84: Family health history, preventing heart disease, metabolic health, strength training efficiency, dementia risk reduction, NAD supplements, and hydration</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		<enclosure url="https://peterattiamd.com/mp-files/390-ama-84-full-audio.mp3/" length="0" type="audio/mpeg" />

			</item>
		<item>
		<title>Disappointing results from the first rapamycin-plus-exercise trial</title>
		<link>https://peterattiamd.com/rapamycin-plus-exercise-trial/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 02 May 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All exercise]]></category>
		<category><![CDATA[All medications & supplements]]></category>
		<category><![CDATA[Exercise]]></category>
		<category><![CDATA[Medications & supplements]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Rapamycin]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38063</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">Why a single negative trial hasn’t diminished my interest in rapamycin as a potential geroprotector</span></p>
<p>The post <a href="https://peterattiamd.com/rapamycin-plus-exercise-trial/">Disappointing results from the first rapamycin-plus-exercise trial</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Reducing cardiovascular risk: a playbook for lipid-lowering pharmacotherapy</title>
		<link>https://peterattiamd.com/lipid-lowering-pharmacotherapy/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Tue, 28 Apr 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All risks]]></category>
		<category><![CDATA[Cardiovascular Disease]]></category>
		<category><![CDATA[Cholesterol]]></category>
		<category><![CDATA[Premium Articles]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[cholesterol]]></category>
		<category><![CDATA[LDL]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37758</guid>

					<description><![CDATA[<p>Risk-stratified targets and a six-step playbook for choosing, combining, and escalating lipid-lowering therapy</p>
<p>The post <a href="https://peterattiamd.com/lipid-lowering-pharmacotherapy/">Reducing cardiovascular risk: a playbook for lipid-lowering pharmacotherapy</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>#389 &#8211; Thinking scientifically: why it&#8217;s hard, why it matters, and a practical toolkit</title>
		<link>https://peterattiamd.com/thinkingscientifically/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 27 Apr 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[Mental models]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[Understanding science]]></category>
		<category><![CDATA[Critical thinking]]></category>
		<category><![CDATA[scientific method]]></category>
		<category><![CDATA[Studying studies]]></category>
		<category><![CDATA[Thinking - learning]]></category>
		<category><![CDATA[Thinking - mental models]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37844</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">“</span><i><span style="font-weight: 400;">The goal of thinking scientifically is not simply to be right. It's to be less wrong over time. Science is a process built around that principle.</span></i><span style="font-weight: 400;">” —Peter Attia</span></p>
<p>The post <a href="https://peterattiamd.com/thinkingscientifically/">#389 &#8211; Thinking scientifically: why it&#8217;s hard, why it matters, and a practical toolkit</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>There is no safe gamble with high LDL cholesterol</title>
		<link>https://peterattiamd.com/there-is-no-safe-gamble-with-high-ldl-cholesterol/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 25 Apr 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All exercise]]></category>
		<category><![CDATA[All risks]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cognitive Health & Neurodegenerative Disease]]></category>
		<category><![CDATA[Exercise]]></category>
		<category><![CDATA[Family Medical History & Genetics]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Understanding science]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Diseases - Alzheimer's disease]]></category>
		<category><![CDATA[Molecules - mRNA]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=38003</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">The pitfalls of the lipid energy model and why “lean mass hyper-responders” should still take high LDL cholesterol seriously. </span></p>
<p>The post <a href="https://peterattiamd.com/there-is-no-safe-gamble-with-high-ldl-cholesterol/">There is no safe gamble with high LDL cholesterol</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>#388 — Prostate cancer screening: why current PSA guidelines are failing men and how modern tools improve early detection and save lives</title>
		<link>https://peterattiamd.com/prostatecancerscreening/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 20 Apr 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[Cancer - cancer screening]]></category>
		<category><![CDATA[Cancer - prostate cancer]]></category>
		<category><![CDATA[Diseases - cancer]]></category>
		<category><![CDATA[Prostate]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37695</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">“</span><i><span style="font-weight: 400;">The timing of when you find the cancer is not a minor detail, it's arguably the determining factor in life and death.</span></i><span style="font-weight: 400;">” —Peter Attia</span></p>
<p>The post <a href="https://peterattiamd.com/prostatecancerscreening/">#388 — Prostate cancer screening: why current PSA guidelines are failing men and how modern tools improve early detection and save lives</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Prostate cancer: a PSA on PSA</title>
		<link>https://peterattiamd.com/prostate-cancer-psa/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 18 Apr 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All risks]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Cancer - prostate cancer]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37492</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">We have the tools to catch prostate cancer early—why aren’t we using them?</span></p>
<p>The post <a href="https://peterattiamd.com/prostate-cancer-psa/">Prostate cancer: a PSA on PSA</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>#387 &#8211; AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field</title>
		<link>https://peterattiamd.com/ama83/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 13 Apr 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[All risks]]></category>
		<category><![CDATA[Ask Me Anything (AMA)]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cardiovascular Disease]]></category>
		<category><![CDATA[Cholesterol]]></category>
		<category><![CDATA[Cognitive Health & Neurodegenerative Disease]]></category>
		<category><![CDATA[Insulin Resistance]]></category>
		<category><![CDATA[Longevity]]></category>
		<category><![CDATA[Longevity medications & supplements]]></category>
		<category><![CDATA[Medications & supplements]]></category>
		<category><![CDATA[Metabolic health]]></category>
		<category><![CDATA[Nutrition]]></category>
		<category><![CDATA[Protein]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Supplements]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[Cardiovascular Disease (CVD)]]></category>
		<category><![CDATA[Drugs - rapalogs]]></category>
		<category><![CDATA[Drugs - rapamycin]]></category>
		<category><![CDATA[Hormones]]></category>
		<category><![CDATA[Nutrients - amino acids]]></category>
		<category><![CDATA[Nutrients - protein]]></category>
		<category><![CDATA[Nutritional biochemistry - protein]]></category>
		<category><![CDATA[Peptides - C-peptide]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[Rapamycin]]></category>
		<category><![CDATA[Supplements - peptides]]></category>
		<category><![CDATA[Supplements - whey protein]]></category>
		<category><![CDATA[Treatments - HRT]]></category>
		<category><![CDATA[Treatments - TRT]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37501</guid>

					<description><![CDATA[<p>“<em>The big picture is that peptides are a legitimate, powerful class of therapeutics, but the legitimacy is confined to a relatively narrow subset of them.</em>” —Peter Attia</p>
<p>The post <a href="https://peterattiamd.com/ama83/">#387 &#8211; AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		<enclosure url="https://peterattiamd.com/mp-files/387-ama-83-full-audio.mp3/" length="0" type="audio/mpeg" />

			</item>
		<item>
		<title>Research Worth Sharing, April 2026 Edition</title>
		<link>https://peterattiamd.com/research-worth-sharing-april-2026/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 11 Apr 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All exercise]]></category>
		<category><![CDATA[All risks]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cognitive Health & Neurodegenerative Disease]]></category>
		<category><![CDATA[Exercise]]></category>
		<category><![CDATA[Family Medical History & Genetics]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Understanding science]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Diseases - Alzheimer's disease]]></category>
		<category><![CDATA[Molecules - mRNA]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37477</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">Paternal exercise shaping offspring fitness via sperm microRNAs, mRNA COVID vaccines enhancing cancer immunotherapy, light-and-sound stimulation as a low-risk Alzheimer’s treatment, and autonomic nervous system imbalance as a unifying theory of aging</span></p>
<p>The post <a href="https://peterattiamd.com/research-worth-sharing-april-2026/">Research Worth Sharing, April 2026 Edition</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>#386 &#8211; Aging clocks—what they measure, how they work, and their clinical and real-world relevance</title>
		<link>https://peterattiamd.com/agingclocks/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 06 Apr 2026 04:15:00 +0000</pubDate>
				<category><![CDATA[All longevity]]></category>
		<category><![CDATA[All other tactics, tolls, & treatments]]></category>
		<category><![CDATA[Ask Me Anything (AMA)]]></category>
		<category><![CDATA[Longevity]]></category>
		<category><![CDATA[Other tactics, tools, & treatments]]></category>
		<category><![CDATA[The Peter Attia Drive Podcast]]></category>
		<category><![CDATA[Aging]]></category>
		<category><![CDATA[Aging clocks]]></category>
		<category><![CDATA[biological age clocks]]></category>
		<category><![CDATA[dna]]></category>
		<category><![CDATA[Epigenetics - epigenetic clocks]]></category>
		<category><![CDATA[Genes - DNA]]></category>
		<category><![CDATA[longevity]]></category>
		<category><![CDATA[Methylation]]></category>
		<category><![CDATA[Tests - DNA tests]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37443</guid>

					<description><![CDATA[<p>"<em>The biomarkers that capture aspects of the aging process could help us prioritize which ideas are worth testing more rigorously and putting more resources into</em>.” —Peter Attia</p>
<p>The post <a href="https://peterattiamd.com/agingclocks/">#386 &#8211; Aging clocks—what they measure, how they work, and their clinical and real-world relevance</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Updated cardiovascular guidelines—statin use in patients as young as 30</title>
		<link>https://peterattiamd.com/statin-use-in-patients-as-young-as-30/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All medications & supplements]]></category>
		<category><![CDATA[All risks]]></category>
		<category><![CDATA[Cardiovascular Disease]]></category>
		<category><![CDATA[Medications]]></category>
		<category><![CDATA[Medications & supplements]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[Cardiovascular Disease (CVD)]]></category>
		<category><![CDATA[cholesterol]]></category>
		<category><![CDATA[Drugs - statins]]></category>
		<category><![CDATA[LDL]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37461</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">Recommendations still may not be aggressive enough, but the needle is moving</span></p>
<p>The post <a href="https://peterattiamd.com/statin-use-in-patients-as-young-as-30/">Updated cardiovascular guidelines—statin use in patients as young as 30</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Thinking in trade-offs: a necessary antidote to diet tribalism</title>
		<link>https://peterattiamd.com/a-necessary-antidote-to-diet-tribalism/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Mon, 30 Mar 2026 18:00:00 +0000</pubDate>
				<category><![CDATA[All nutrition]]></category>
		<category><![CDATA[Nutrition]]></category>
		<category><![CDATA[Premium Articles]]></category>
		<category><![CDATA[Diets]]></category>
		<category><![CDATA[Diets - ketogenic diet]]></category>
		<category><![CDATA[Diets - vegan]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37399</guid>

					<description><![CDATA[<p>Finding a diet that sustainably works for you is enough of a win. Why pretend it has no downsides?</p>
<p>The post <a href="https://peterattiamd.com/a-necessary-antidote-to-diet-tribalism/">Thinking in trade-offs: a necessary antidote to diet tribalism</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		<enclosure url="https://peterattiamd.com/mp-files/thinking-in-trade-offs-a-necessary-antidote-to-diet-tribalism.mp3/" length="0" type="audio/mpeg" />

			</item>
		<item>
		<title>Protect the eyes, protect the brain—a potentially simple lever for dementia risk</title>
		<link>https://peterattiamd.com/cataracts-and-dementia/</link>
		
		<dc:creator><![CDATA[Peter Attia]]></dc:creator>
		<pubDate>Sat, 28 Mar 2026 11:00:00 +0000</pubDate>
				<category><![CDATA[All risks]]></category>
		<category><![CDATA[Cognitive Health & Neurodegenerative Disease]]></category>
		<category><![CDATA[Risks]]></category>
		<category><![CDATA[Weekly Newsletter]]></category>
		<category><![CDATA[dementia]]></category>
		<category><![CDATA[Eyes]]></category>
		<guid isPermaLink="false">https://peterattiamd.com/?p=37397</guid>

					<description><![CDATA[<p><span style="font-weight: 400;">Uncorrected cataracts may do more than blur your vision. A recent meta-analysis explores what restoring sight could mean for long-term dementia risk.</span></p>
<p>The post <a href="https://peterattiamd.com/cataracts-and-dementia/">Protect the eyes, protect the brain—a potentially simple lever for dementia risk</a> appeared first on <a href="https://peterattiamd.com">Peter Attia</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
